United States Alzheimer?s Disease Diagnostic Market Report 2017

November 2017 | 98 pages | ID: U7757DF45FDWEN
QYResearch

Abstracts

In this report, the United States Alzheimer?s Disease Diagnostic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Alzheimer?s Disease Diagnostic in these regions, from 2012 to 2022 (forecast).
United States Alzheimer?s Disease Diagnostic market competition by top manufacturers/players, with Alzheimer?s Disease Diagnostic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly and Company (UK)
• TauRx (Republic of Singapore)
• Alector LLC (US)
• Accera (US)
• Treventis Corporation (US)
• Neuro-Bio Ltd (UK)
• Cognition Therapeutics (US)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Early-onset Alzheimer's
• Late-onset Alzheimer's
• Familial Alzheimer's Disease

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Alzheimer?s Disease Diagnostic for each application, including

• Clinics
• Hospitals
• Diagnostic Centers
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Alzheimer?s Disease Diagnostic Market Report 2017

1 ALZHEIMER?S DISEASE DIAGNOSTIC OVERVIEW

1.1 Product Overview and Scope of Alzheimer?s Disease Diagnostic
1.2 Classification of Alzheimer?s Disease Diagnostic by Product Category
  1.2.1 United States Alzheimer?s Disease Diagnostic Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Alzheimer?s Disease Diagnostic Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Early-onset Alzheimer's
  1.2.4 Late-onset Alzheimer's
  1.2.5 Familial Alzheimer's Disease
1.3 United States Alzheimer?s Disease Diagnostic Market by Application/End Users
  1.3.1 United States Alzheimer?s Disease Diagnostic Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinics
  1.3.3 Hospitals
  1.3.4 Diagnostic Centers
  1.3.5 Others
1.4 United States Alzheimer?s Disease Diagnostic Market by Region
  1.4.1 United States Alzheimer?s Disease Diagnostic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
  1.4.3 Southwest Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
  1.4.5 New England Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
  1.4.6 The South Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
  1.4.7 The Midwest Alzheimer?s Disease Diagnostic Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Alzheimer?s Disease Diagnostic (2012-2022)
  1.5.1 United States Alzheimer?s Disease Diagnostic Sales and Growth Rate (2012-2022)
  1.5.2 United States Alzheimer?s Disease Diagnostic Revenue and Growth Rate (2012-2022)

2 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Alzheimer?s Disease Diagnostic Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Alzheimer?s Disease Diagnostic Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Alzheimer?s Disease Diagnostic Average Price by Players/Suppliers (2012-2017)
2.4 United States Alzheimer?s Disease Diagnostic Market Competitive Situation and Trends
  2.4.1 United States Alzheimer?s Disease Diagnostic Market Concentration Rate
  2.4.2 United States Alzheimer?s Disease Diagnostic Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Alzheimer?s Disease Diagnostic Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Alzheimer?s Disease Diagnostic Sales and Market Share by Region (2012-2017)
3.2 United States Alzheimer?s Disease Diagnostic Revenue and Market Share by Region (2012-2017)
3.3 United States Alzheimer?s Disease Diagnostic Price by Region (2012-2017)

4 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Alzheimer?s Disease Diagnostic Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Alzheimer?s Disease Diagnostic Revenue and Market Share by Type (2012-2017)
4.3 United States Alzheimer?s Disease Diagnostic Price by Type (2012-2017)
4.4 United States Alzheimer?s Disease Diagnostic Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Alzheimer?s Disease Diagnostic Sales and Market Share by Application (2012-2017)
5.2 United States Alzheimer?s Disease Diagnostic Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly and Company (UK)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly and Company (UK) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 TauRx (Republic of Singapore)
  6.2.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 TauRx (Republic of Singapore) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Alector LLC (US)
  6.3.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Alector LLC (US) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Accera (US)
  6.4.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Accera (US) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Treventis Corporation (US)
  6.5.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Treventis Corporation (US) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Neuro-Bio Ltd (UK)
  6.6.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Neuro-Bio Ltd (UK) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cognition Therapeutics (US)
  6.7.2 Alzheimer?s Disease Diagnostic Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cognition Therapeutics (US) Alzheimer?s Disease Diagnostic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ALZHEIMER?S DISEASE DIAGNOSTIC MANUFACTURING COST ANALYSIS

7.1 Alzheimer?s Disease Diagnostic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Alzheimer?s Disease Diagnostic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Alzheimer?s Disease Diagnostic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Alzheimer?s Disease Diagnostic Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALZHEIMER?S DISEASE DIAGNOSTIC MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Alzheimer?s Disease Diagnostic Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Alzheimer?s Disease Diagnostic Sales Volume Forecast by Type (2017-2022)
11.3 United States Alzheimer?s Disease Diagnostic Sales Volume Forecast by Application (2017-2022)
11.4 United States Alzheimer?s Disease Diagnostic Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Alzheimer?s Disease Diagnostic
Figure United States Alzheimer?s Disease Diagnostic Market Size (K Units) by Type (2012-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume Market Share by Type (Product Category) in 2016
Figure Early-onset Alzheimer's Product Picture
Figure Late-onset Alzheimer's Product Picture
Figure Familial Alzheimer's Disease Product Picture
Figure United States Alzheimer?s Disease Diagnostic Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Alzheimer?s Disease Diagnostic by Application in 2016
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostic Centers Examples
Table Key Downstream Customer in Diagnostic Centers
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Alzheimer?s Disease Diagnostic Market Size (Million USD) by Region (2012-2022)
Figure The West Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales (K Units) and Growth Rate (2012-2022)
Figure United States Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Alzheimer?s Disease Diagnostic Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alzheimer?s Disease Diagnostic Sales Share by Players/Suppliers
Figure 2017 United States Alzheimer?s Disease Diagnostic Sales Share by Players/Suppliers
Figure United States Alzheimer?s Disease Diagnostic Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Alzheimer?s Disease Diagnostic Revenue Share by Players/Suppliers
Figure 2017 United States Alzheimer?s Disease Diagnostic Revenue Share by Players/Suppliers
Table United States Market Alzheimer?s Disease Diagnostic Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Alzheimer?s Disease Diagnostic Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Alzheimer?s Disease Diagnostic Market Share of Top 3 Players/Suppliers
Figure United States Alzheimer?s Disease Diagnostic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Alzheimer?s Disease Diagnostic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Alzheimer?s Disease Diagnostic Product Category
Table United States Alzheimer?s Disease Diagnostic Sales (K Units) by Region (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales Share by Region (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Share by Region (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Market Share by Region in 2016
Table United States Alzheimer?s Disease Diagnostic Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Revenue Share by Region (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Revenue Market Share by Region (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Revenue Market Share by Region in 2016
Table United States Alzheimer?s Disease Diagnostic Price (USD/Unit) by Region (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales (K Units) by Type (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales Share by Type (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Share by Type (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Market Share by Type in 2016
Table United States Alzheimer?s Disease Diagnostic Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Alzheimer?s Disease Diagnostic by Type (2012-2017)
Figure Revenue Market Share of Alzheimer?s Disease Diagnostic by Type in 2016
Table United States Alzheimer?s Disease Diagnostic Price (USD/Unit) by Types (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Growth Rate by Type (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales (K Units) by Application (2012-2017)
Table United States Alzheimer?s Disease Diagnostic Sales Market Share by Application (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Market Share by Application (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Market Share by Application in 2016
Table United States Alzheimer?s Disease Diagnostic Sales Growth Rate by Application (2012-2017)
Figure United States Alzheimer?s Disease Diagnostic Sales Growth Rate by Application (2012-2017)
Table Eli Lilly and Company (UK) Basic Information List
Table Eli Lilly and Company (UK) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company (UK) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company (UK) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company (UK) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table TauRx (Republic of Singapore) Basic Information List
Table TauRx (Republic of Singapore) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TauRx (Republic of Singapore) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure TauRx (Republic of Singapore) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure TauRx (Republic of Singapore) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Alector LLC (US) Basic Information List
Table Alector LLC (US) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alector LLC (US) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Alector LLC (US) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Alector LLC (US) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Accera (US) Basic Information List
Table Accera (US) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accera (US) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Accera (US) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Accera (US) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Treventis Corporation (US) Basic Information List
Table Treventis Corporation (US) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Treventis Corporation (US) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Treventis Corporation (US) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Treventis Corporation (US) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Neuro-Bio Ltd (UK) Basic Information List
Table Neuro-Bio Ltd (UK) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Neuro-Bio Ltd (UK) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Neuro-Bio Ltd (UK) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Neuro-Bio Ltd (UK) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Cognition Therapeutics (US) Basic Information List
Table Cognition Therapeutics (US) Alzheimer?s Disease Diagnostic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cognition Therapeutics (US) Alzheimer?s Disease Diagnostic Sales Growth Rate (2012-2017)
Figure Cognition Therapeutics (US) Alzheimer?s Disease Diagnostic Sales Market Share in United States (2012-2017)
Figure Cognition Therapeutics (US) Alzheimer?s Disease Diagnostic Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer?s Disease Diagnostic
Figure Manufacturing Process Analysis of Alzheimer?s Disease Diagnostic
Figure Alzheimer?s Disease Diagnostic Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer?s Disease Diagnostic Major Players/Suppliers in 2016
Table Major Buyers of Alzheimer?s Disease Diagnostic
Table Distributors/Traders List
Figure United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Type in 2022
Table United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Application in 2022
Table United States Alzheimer?s Disease Diagnostic Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Alzheimer?s Disease Diagnostic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Alzheimer?s Disease Diagnostic Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources